These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews. Clerico M; Rivoiro C; Contessa G; Viglietti D; Durelli L Clin Neurol Neurosurg; 2008 Nov; 110(9):878-85. PubMed ID: 18164542 [TBL] [Abstract][Full Text] [Related]
11. Future research directions in multiple sclerosis therapies. Greenberg BM; Calabresi PA Semin Neurol; 2008 Feb; 28(1):121-7. PubMed ID: 18256992 [TBL] [Abstract][Full Text] [Related]
12. Concepts of induction and escalation therapy in multiple sclerosis. Rieckmann P J Neurol Sci; 2009 Feb; 277 Suppl 1():S42-5. PubMed ID: 19200866 [TBL] [Abstract][Full Text] [Related]
13. [Advances in the treatment of multiple sclerosis?]. Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968 [TBL] [Abstract][Full Text] [Related]
14. Modern multiple sclerosis treatment - what is approved, what is on the horizon. Pilz G; Wipfler P; Ladurner G; Kraus J Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508 [TBL] [Abstract][Full Text] [Related]
15. Knowns and unknowns in the future of multiple sclerosis treatment. Stüve O J Neurol Sci; 2009 Dec; 287 Suppl 1():S30-6. PubMed ID: 20106346 [TBL] [Abstract][Full Text] [Related]
16. Treatment options for multiple sclerosis: current and emerging therapies. Gawronski KM; Rainka MM; Patel MJ; Gengo FM Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847 [TBL] [Abstract][Full Text] [Related]